A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer

Overview

Journal Integr Cancer Ther

Publisher Sage Publications

Specialties Oncology
Pharmacology

Date 2020 Dec 28

PMID 33356632

Citations 2

Authors

Ellen Conte

Mark Legacy

Athanasios Psihogios

Anne Pitman

Andrea Redway

Jill Hamer-Wilson

Dugald Seely

Affiliations

Soon will be listed here.

Abstract

Background: Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to inform future changes to the program.

Objectives: (1) Assess the feasibility of the program and its evaluation; (2) pilot the collection of patient-reported outcomes; (3) identify outcomes that may be positively influenced; and (4) inform program modifications.

Methods: Participants were recruited from the first session of Inspire Now for an observational pilot study. The primary outcome was feasibility. Secondary outcomes included within-person changes in Functional Assessment of Cancer Therapy - Lung (FACT-L) and Measure Yourself Concerns and Wellbeing (MYCaW), and program satisfaction and qualitative experiences of participants and facilitators through internally-developed questionnaires and semi-structured interviews. Analysis was primarily descriptive, within person changes in FACT-L and MYCaW were analyzed using the Wilcoxon signed-rank test and qualitative data was assessed for common themes.

Results: The program and its evaluation were feasible; 8 of 9 (89%) participants consented to the study, median attendance was 6 of 6 sessions (IQR 4.5-6), and questionnaire completion was 100% at baseline and 75% at follow-up. There were clinically meaningful improvements in MYCaW concern 1 (-1.2, 95% CI -2.0 to -0.4) and overall wellbeing (-0.9, 95% CI -2.1 to 0.4). Seven of eight FACT-L sub-sections trended toward improvement, with absolute changes ranging from -1.7 to 10.8%. Participant feedback was overwhelmingly positive; group support and social interactions were highly valued.

Conclusions: The group intervention for people with lung cancer was feasible to both run and evaluate. Participants responded positively to the program. Findings will inform changes to future sessions and an analysis of multiple sessions is planned.

Citing Articles

"The Ability to Go Out into the World Is the Most Important Thing"-A Qualitative Study of Important Exercise Outcomes for People with Lung Cancer.

Bowman A, Denehy L, McDonald C, Edbrooke L Curr Oncol. 2024; 31(2):733-746.

PMID: 38392048 PMC: 10887680. DOI: 10.3390/curroncol31020054.

Mixed methods research in complementary and alternative medicine: a scoping review.

Wanqing D, Liuding W, Min J, Xiao L, Bo L, Yunling Z J Tradit Chin Med. 2022; 42(4):652-666.

PMID: 35848983 PMC: 9924665. DOI: 10.19852/j.cnki.jtcm.20220602.002.

References

Howell D, Molloy S, Wilkinson K, Green E, Orchard K, Wang K . Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015; 26(9):1846-1858. DOI: 10.1093/annonc/mdv181. View

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

Fouladbakhsh J, Davis J, Yarandi H . Using a standardized Viniyoga protocol for lung cancer survivors: a pilot study examining effects on breathing ease. J Complement Integr Med. 2013; 10. DOI: 10.1515/jcim-2012-0013. View

Polley M, Seers H, Cooke H, Hoffman C, Paterson C . How to summarise and report written qualitative data from patients: a method for use in cancer support care. Support Care Cancer. 2007; 15(8):963-71. DOI: 10.1007/s00520-007-0283-2. View

Carter A, Nguyen C . A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding. BMC Public Health. 2012; 12:526. PMC: 3411479. DOI: 10.1186/1471-2458-12-526. View

Maguire R, Papadopoulou C, Kotronoulas G, Simpson M, McPhelim J, Irvine L . A systematic review of supportive care needs of people living with lung cancer. Eur J Oncol Nurs. 2012; 17(4):449-64. DOI: 10.1016/j.ejon.2012.10.013. View

Cella D, Eton D, Fairclough D, Bonomi P, Heyes A, Silberman C . What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol. 2002; 55(3):285-95. DOI: 10.1016/s0895-4356(01)00477-2. View

Coronado A, Finley C, Badovinac K, Han J, Niu J, Rahal R . Discrepancies between Canadian cancer research funding and site-specific cancer burden: a spotlight on ten disease sites. Curr Oncol. 2018; 25(5):338-341. PMC: 6209562. DOI: 10.3747/co.25.4230. View

Chen S, Chiou S, Yu C, Lee Y, Liao W, Hsieh P . The unmet supportive care needs-what advanced lung cancer patients' caregivers need and related factors. Support Care Cancer. 2016; 24(7):2999-3009. DOI: 10.1007/s00520-016-3096-3. View

10.

Milbury K, Mallaiah S, Lopez G, Liao Z, Yang C, Carmack C . Vivekananda Yoga Program for Patients With Advanced Lung Cancer and Their Family Caregivers. Integr Cancer Ther. 2015; 14(5):446-51. PMC: 4537807. DOI: 10.1177/1534735415583554. View

11.

Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S . What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014; 32(14):1480-501. DOI: 10.1200/JCO.2013.53.5948. View

12.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

13.

Jolliffe R, Seers H, Jackson S, Caro E, Weeks L, Polley M . The responsiveness, content validity, and convergent validity of the Measure Yourself Concerns and Wellbeing (MYCaW) patient-reported outcome measure. Integr Cancer Ther. 2014; 14(1):26-34. DOI: 10.1177/1534735414555809. View

14.

Polley M, Jolliffe R, Boxell E, Zollman C, Jackson S, Seers H . Using a Whole Person Approach to Support People With Cancer: A Longitudinal, Mixed-Methods Service Evaluation. Integr Cancer Ther. 2016; 15(4):435-445. PMC: 5739159. DOI: 10.1177/1534735416632060. View

15.

Papadakos J, Charow R, Papadakos C, Moody L, Giuliani M . Evaluating cancer patient-reported outcome measures: Readability and implications for clinical use. Cancer. 2019; 125(8):1350-1356. DOI: 10.1002/cncr.31928. View

16.

Deng G, Rausch S, Jones L, Gulati A, Kumar N, Greenlee H . Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl):e420S-e436S. DOI: 10.1378/chest.12-2364. View

17.

Tran K, Zomer S, Chadder J, Earle C, Fung S, Liu J . Measuring patient-reported outcomes to improve cancer care in Canada: an analysis of provincial survey data. Curr Oncol. 2018; 25(2):176-179. PMC: 5927789. DOI: 10.3747/co.25.3995. View

18.

Barassi G, Bellomo R, Di Iulio A, Lococo A, Porreca A, Di Felice P . Preoperative Rehabilitation in Lung Cancer Patients: Yoga Approach. Adv Exp Med Biol. 2018; 1096:19-29. DOI: 10.1007/5584_2018_186. View

19.

Cella D, Bonomi A, Lloyd S, Tulsky D, Kaplan E, Bonomi P . Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995; 12(3):199-220. DOI: 10.1016/0169-5002(95)00450-f. View

20.

Giuliani M, Milne R, Puts M, Sampson L, Kwan J, Le L . The prevalence and nature of supportive care needs in lung cancer patients. Curr Oncol. 2016; 23(4):258-65. PMC: 4974033. DOI: 10.3747/co.23.3012. View